Form 4 for IMA ImageneBio, Inc.
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-18 · accession 0000899243-22-002657 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-20 | 2022-01-18 | IMA | Tessier Maude | Chief Business Off | M - OptEx | $3.54 | +71.8K | 67.7K | New | +$253.8K |
| DM | 2022-01-20 | 2022-01-18 | IMA | Tessier Maude | Chief Business Off | M - OptEx | $0.00 | -71.8K | 5,560 | -93% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-18 | M | A | 8,265 | $4.51 | 100,578 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-18 | M | A | 24,606 | $4.15 | 92,313 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-18 | M | A | 38,915 | $2.94 | 67,707 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-01-18 | M | D | 24,606 | $0.00 | 11,186 | D | $4.15 · — to 2029-03-19 | 24,606 Common Stock | (F2) 25% of this option vested and became exercisable on March 20, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-18 | M | D | 8,265 | $0.00 | 28,963 | D | $4.51 · — to 2029-12-05 | 8,265 Common Stock | (F3) 25% of this option vested and became exercisable on December 6, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-18 | M | D | 38,915 | $0.00 | 5,560 | D | $2.94 · — to 2028-08-08 | 38,915 Common Stock | (F1) 25% of this option vested and became exercisable on July 16, 2019, with the remainder vesting in 36 substantially equal monthly installments thereafter. |